Symposia
- Date:
- Time: -
- Track: Clinical Practice
- CME/CE: 1.0
- Options: Also available on-demand
Co-Moderators: Esther S. Oh, MD, PhD & Julie Bynum, MD, MPH
This session will address biomarker and clinical assessments for the diagnosis of AD and will describe the current state of the science on amyloid antibodies. Learning Objectives: (1) utilize clinical and biomarker approaches to diagnosing Alzheimer's Disease (AD); (2) compare and contrast disease-modifying therapies for Alzheimer's Disease.
| State of the Science: Clinical and Biomarker Approaches to Diagnosing Alzheimer's Disease Jason Karlawish, MD |
| State of the Science: Therapeutics for Alzheimer’s Disease Esther S. Oh, MD, PhD |